ObsEva's Series B Round

ObsEva raised a round of funding on November 23, 2015.

ObsEva is a Swiss-based, speciality biopharmaceutical company dedicated to the development of drugs for women's reproductive medicine. ObsEva's main focus is on therapies for preterm labor.…

Articles about ObsEva's Series B Round: